Asston Pharmaceuticals' Board will meet on 30th March 2026 to consider multiple key management appointments.
Agenda includes appointment of CFO, two Additional Directors, and noting statutory auditor appointment via circular resolution.
Board will also consider approving the date and notice for an Extraordinary General Meeting of the Company.